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Abstract
Background: To investigate the association of serum uric acid (SUA) with cardiometabolic abnormalities in
Caucasian overweight/obese children (<10 years of age) versus adolescents (≥10 years of age) by drawing age and
gender specific percentiles of uric acid.
Methods: Cross-sectional evaluation of 1364 Caucasian overweight/obese patients (age 4.1–17.9 years; 726 males,
53%; 560 children, 41%).
Results: SUA levels were significantly lower in children than in adolescents (4.74 ± 1.05 vs. 5.52 ± 1.49 mg/dl,
p < 0.001) and peaked in 12–14 years-old boys and 10–12 years-old girls.
In children with levels of SUA in the highest quartile (N = 75, 13%), OR for high triglycerides was 4.145, 95% CI 1.
506–11.407 (p = 0.009). In adolescents with SUA in the highest quartile (N = 274, 34%), ORs for insulin resistance was
2.399 (95%CI 1.4–4.113; p < 0.001); for impaired fasting glucose 2.184 (95% CI 0.877–5.441; p = 0.07); for impaired
glucose tolerance 2.390 (95% CI 1.405–4.063; p = 0.001); and for high triglycerides 1.8, (95%CI 0.950–3.420; p = 0.05).
Multivariable random-effect linear regression models demonstrated that waist circumference and age (p < 0.0001 for
both) are the variables most significantly predicting SUA levels, followed by triglycerides (p = 0.005) and 2 h glucose
(p = 0.03) while HOMA-IR and BMI z-score did not predict SUA.
Conclusions: High uric acid is associated with metabolic abnormalities and particularly with waist circumference
very early in childhood.
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Background
Uric acid is the end-product of dietary and endogenous
purine metabolism and results from the balance between
hepatic production and renal excretion [1]. Serum uric
acid (SUA) is an independent risk factor for atheroscler-
osis and cardiovascular disease (CVD) in adults [1–3]
being associated in prospective studies with risk of de-
veloping metabolic syndrome (MetS), type 2 diabetes
(T2D) and incident cardiovascular events [4].
In childhood and adolescence, SUA levels increase
progressively from early childhood with body growth
and plateau by ~15–17 years of age [5]. Concentrations
in overweight and obese individuals are higher than in
normal-weight peers [6, 7] and are associated with insulin
resistance (IR) [8], cardiometabolic abnormalities belonging
to the MetS [7–9], greater waist circumference (WC) [10],
incident hypertension [11], increased carotid intima-media
thickness [12] and impaired flow mediated dilation [13].
Recent studies focused on the association between SUA
and cardiometabolic risk in young obese patients of differ-
ent age-groups including prepubertal children [13–15].
The current study aims at investigating the association of
serum uric acid with insulin resistance, disturbed carbohy-
drate metabolism, dyslipidemia and waist circumference in
* Correspondence: melania.manco@opbg.net
2Scientific Directorate, Bambino Gesù Children’s Hospital, Rome, Italy
4Scientific Directorate, Research Unit for Multifactorial Disease, Bambino Gesù
Children’s Hospital, Rome, Italy
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Luciano et al. Italian Journal of Pediatrics  (2017) 43:3 
DOI 10.1186/s13052-016-0321-0
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The study population includes 1364 Caucasian over-
weight/obese children and adolescents (age range 4.18–
17.93 years), referred by general practitioners to the Unit
of Clinical Nutrition at the Bambino Gesù Children’s
Hospital between July 2012 and 2013 [16]. Patients under-
went anthropometric measurements, laboratory evalu-
ation of uric acid, fasting glucose and insulin, lipid profile,
liver function tests, white blood cell count (WBC); and a
standard oral glucose tolerance test (OGTT). No child
had genetic, renal or endocrine diseases, chronic illness,
consumption of drugs affecting growth and carbohydrate
metabolism, family history of symptomatic hyperuricemia.
Anthropometric evaluation
Weight was measured with scales certified for medical use
(90/384/EEC, SECA) with a precision of 50 g with children
wearing minimal clothing and weight recorded to the near-
est 100 g. Height was measured with a Holtain stadiometer
and recorded to the nearest 0.5 cm. The average of two
measurements was used. Children were classified as over-
weight/obese if BMI was ≥85th percentile according to
Italian references [17]. WC was measured midway between
the superior border of the iliac crest and the lower margin
of the ribs at the end of normal expiration.
Biochemical assays and estimation of IR
All the participants were asked to refrain from intensive
physical activity in the 3 days prior to the study and
were prescribed a standardized diet. Fasting blood sam-
ples were drawn after 8–12 h fast. Glucose and insulin
levels were measured every 30 min starting from base-
line up to 120 min following the OGTT (1.75 g of glu-
cose/kg body weight up to a maximum of 75 g). The
HOmeostasis Model Assessment of IR index (HOMA-
IR) was calculated as average on two blood samples (-5
and 0 min) as [fasting glucose (mg/dl) x fasting insulin
(μU/ml)/405]. Insulin sensitivity index (ISI) was calculated
as [ISI = 10,000/√(fasting glucose × fasting insulin) × (mean
glucose ×mean insulin).
SUA, glucose, total cholesterol, high-density lipopro-
tein (HDL) cholesterol, triglycerides, alanine aminotrans-
ferase (ALT) and gamma-glutamyl transferase (γ-GT)
were measured by using commercial methods (ADVIA
1800 Chemistry System, Siemens Healthcare Diagnostic,
Deerfield, IL). Serum insulin was analyzed by a chemilu-
minescent immunoassay method (ADVIA Centaur XP
Immunoassay System; Siemens Healthcare Diagnostic,
Deerfield, IL).
Definition of metabolic abnormalities
Dyslipidemia was diagnosed in the presence of at least one
of the following conditions: value of cholesterol and/or tri-
glycerides higher than the 95th percentile and/or HDL
cholesterol lower than the 5th for age and sex according to
the American Academy of Pediatrics [18]. The triglycer-
ides to HDL-cholesterol ratio >2.2 was considered athero-
genic [19, 20]. Impaired fasting glucose (IFG) was defined
as fasting glucose ≥100 mg/dl; impaired glucose tolerance
(IGT) as 2 h glucose ≥140 mg/dl following the OGTT. In-
sulin resistance was defined as HOMA-IR value ≥75th per-
centile adjusted for age and sex according to reference
value of HOMA-IR in the Italian population as described
elsewhere [21]. Hyperuricemia was defined as SUA
value ≥75th percentile adjusted for age and sex.
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation (SD) and categorical variables as number and
percentage. Normal distribution was tested using the
Kolmogorov-Smirnov test. Between-group comparison
was performed by using the χ2 test for categorical vari-
ables and ORs calculated. The Mann-Whitney U test
was used for comparison of continuous variables. Uric
acid distribution was tabulated for the values corre-
sponding to the 5th, 10th, 25th, 50th, 75th, 90th, and
95th percentiles. Correlations were sought by using the
Spearman test and variables significantly associated with
SUA (age, BMI Z-score, waist circumference, triglycerides,
HOMA-IR and 2 h plasma glucose entered a multivariable
random-effect linear regression models to evaluate the as-
sociation of SUA with metabolic abnormalities.
Statistical analyses were performed using the SPSS 21
statistical package (SPSS, Chicago, IL, USA). A result
with p < 0.05 was considered statistically significant.
Results
Description of the sample
Table 1 describes the study population as a whole, age
and sex subgroups. A total of 1364 overweight/obese pa-
tients were studied, 560 (41%) children, 726 (53.2%)
were males. Dyslipidemia was diagnosed in 366 (26.8%)
patients; low HDL-cholesterol in 29 (2.2%); high total
cholesterol in 252 (18.5%) and high triglycerides in 87
(6.4%). Children affected by dyslipidemia were 162 out
of 560 (29%) and adolescents 204 out of 804 (25.4%).
Disturbed carbohydrate metabolism was found in 94 pa-
tients, [25 children out of 560 (4.4%) and 69 out of 804
adolescents (8.6%)]: 41 with IFG (3%) and 53 with IGT
(3.9%). IR was found in 209 patients (15.3%); 41 children
(7.3%), 168 adolescents (20.9%). Table 2 reports SUA
(mg/dl) in cases with metabolic abnormalities. Figure 1
show percentage of cases presenting with each metabolic
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Table 1 Characteristics of the study population
Total Male Female p value <10 years ≥10 years p value
1364 (N = 726) (N = 638) (N = 560) (N = 804)
Age (years) 10.74 ± 2.70 10.60 ± 2.48 10.83 ± 2.93 0.707 Male 290 (39.9%) 436 (60.1%)
Weight (kg) 60.64 ± 18.74 61.19 ± 18.83 60.00 ± 18.63 0.433 45.98 ± 9.21 70.85 ± 16.82 <0.001
Height (cm) 147.22 ± 14.06 147.97 ± 14.28 146.36 ± 13.77 0.199 134.76 ± 9.31 155.89 ± 9.59 <0.001
Waist circumference (cm) 80.58 ± 10.21 81.95 ± 10.48 78.99 ± 9.65 <0.001 74.56 ± 7.62 84.90 ± 9.63 <0.001
BMI (kg/m2) 27.32 ± 4.36 27.28 ± 4.06 27.34 ± 4.67 0.811 25.13 ± 3.11 28.84 ± 4.45 <0.001
BMI z score (SDS) 2.03 ± 0.51 2.01 ± 0.50 2.06 ± 0.52 0.051 2.00 ± 0.39 2.05 ± 0.58 0.802
HOMA-IR 2.87 ± 1.98 2.75 ± 2.00 3.01 ± 1.94 0.001 2.43 ± 1.79 3.44 ± 1.94 <0.001
ISI 4.12 ± 2.50 4.23 ± 2.18 3.98 ± 2.82 <0.001 2.43 ± 1.79 3.50 ± 2.95 <0.001
Fasting serum glucose (mg/dl) 79.53 ± 10.03 80.38 ± 9.85 78.54 ± 10.15 0.001 78.06 ± 9.93 79.53 ± 10.03 <0.001
2 h serum glucose (mg/dl) 105.01 ± 18.79 105.41 ± 18.94 104.54 ± 18.59 0.367 102.07 ± 18.42 107.04 ± 18.77 <0.001
Fasting insulin (μUI/l) 14.40 ± 9.56 13.67 ± 10.03 15.23 ± 8.92 <0.001 11.57 ± 7.92 16.37 ± 10.10 <0.001
2 h insulin (μUI/l) 81.30 ± 68.17 72.28 ± 59.32 91.65 ± 75.82 <0.001 66.49 ± 63.68 91.50 ± 69.32 <0.001
Uric acid (mg/dl) 5.20 ± 1.38 5.28 ± 1.45 5.10 ± 1.30 0.058 4.74 ± 1.05 5.52 ± 1.49 <0.001
Total cholesterol (mg/dl) 156.46 ± 30.85 158.63 ± 32.82 154.00 ± 28.27 0.005 158.13 ± 28.67 155.30 ± 32.25 0.005
HDL-cholesterol (mg/dl) 48.86 ± 12.51 49.88 ± 13.78 47.70 ± 10.78 0.004 50.73 ± 12.89 47.56 ± 12.08 0.034
Triglycerides (mg/dl) 76.33 ± 41.02 76.84 ± 44.10 75.74 ± 37.01 0.382 71.39 ± 39.30 79.68 ± 41.86 <0.001
ALT (IU/l) 24.54 ± 19.18 26.86 ± 23.68 21.92 ± 11.73 <0.001 23.01 ± 10.74 25.61 ± 23.30 0.649
γ-GT (IU/l) 13.90 ± 8.98 15.02 ± 10.57 12.57 ± 6.41 <0.001 13.30 ± 5.98 14.30 ± 10.52 0.431
Data are expressed as mean ± SD or number and percentage. BMI body mass index, HOMA-IR homeostasis model assessment for insulin resistance, ISI insulin
sensitivity index, HDL-cholesterol high-density lipoprotein cholesterol, TG triglycerides, ALT alanine aminotransferase, γ-GT gamma-glutamyl transferase
Table 2 Mean values of serum uric acid (mg/dl) in children and adolescents with and without metabolic abnormalities
































































































5.1 ± 1.2 6.09 ± 1.4 <0.0001 4.7 ± 1.0 5.3 ± 1.1 0.05 5.4 ± 1.3 6.2 ± 1.5 0.002
Data are expressed as mean ± SD. NFG normal fasting glucose, IFG impaired fasting glucose, NGT normal glucose tolerance, IG impaired glucose tolerance
Luciano et al. Italian Journal of Pediatrics  (2017) 43:3 Page 3 of 7
abnormality and SUAlevels in the highest quartile of the
distribution.
Distribution of serum uric acid
Table 3 reports SUA percentiles from the 5th to 95th in
the population grouped by sex and age. In boys, SUA
rose significantly from >10–12 years to >12–14 years
(p < 0.05) and from >12–14 years to >14 years (p < 0.05).
In girls, SUA increased significantly from >8–10 years
to >10–12 years (p < 0.05) when its levels peaked. Sig-
nificant sex-related differences were found by 10 years
of age. Boys aged 10–12 years had significantly lower
SUA than age-matched girls (5.09 ± 1.30 vs. 5.41 ± 1.36;
p = 0.002). Conversely, males had higher concentra-
tions than girls at 12–14 years of age (6.02 ± 1.77
vs.5.17 ± 1.16; p < 0.001) and onward (6.99 ± 0.99 vs.
5.37 ± 1.56; p < 0.001).
High SUA (SUA ≥75th percentile for age and sex) was
observed in 246 patients (18%), 98 children out of 560
(17.5%) and 148 adolescents out of 804 (18.4%).
Correlations
In the whole sample, there were statistically significant
even weak correlations between SUA and age (ρ = 0.332),
BMI (ρ = 0.416), BMI-z-score (ρ = 0.288), waist circum-
ference (ρ = 0.467), HOMA-IR (ρ = 0.205); TG/HDL ratio
(ρ = 0.218), fasting insulin (ρ = 0.238), ALT (ρ = 0.227) and
ISI (ρ = -0.239) (p < 0.001 for all). SUA was also correlated
with γ-GT (ρ = 0.167), triglycerides (ρ = 0.165), HDL
(ρ = -0.149), fasting glucose (ρ = -0.107, p < 0.001) and ISI
(ρ = -0.239) γ-GT (ρ = 0.167), triglycerides (ρ = 0.165), HDL
(ρ = -0.149), fasting glucose (ρ = -0.107, (p < 0.001 for all).
Multivariable random-effect linear regression models
demonstrated that waist circumference and age (p < 0.0001
for both) are the variables most significantly predicting
Fig. 1 Bars represents 100% of cases with insulin resistance (IR), impaired fasting glucose (IFG), impaired glucose tolerance (IGT), high triglycerides
(TG), low high densitity lipoprotein cholesterol (HDL), metabolic syndrome (MetS). Dark grey are cases with high uric acid above the highest
quartile, light grey cases with uric acid in the lowest quartiles
Table 3 Distribution of serum uric acid (SUA, mg/dl) in overweight/obese patients by sex and age
SUA percentile
Number Age (years) 5th 10th 25th 50th 75th 90th 95th
Male
109 4–8 3.01 3.48 3.98 4.73 5.48 5.98 6.85
178 >8–10 3.29 3.60 3.97 4.60 5.22 6.00 6.30
229 >10–12 3.44 3.80 4.30 4.90 5.70 6.51 6.95
143 >12–14 3.72 4.30 4.90 5.80 6.85 7.86 8.74
67 >14 5.50 5.76 6.20 6.90 7.70 8.32 8.66
Female
104 4–8 3.16 3.29 4.01 4.67 5.22 6.36 6.81
166 >8–10 3.10 3.56 4.10 4.70 5.50 6.10 6.67
161 >10–12 3.80 4.10 4.60 5.30 6.05 6.70 7.19
108 >12–14 3.34 3.60 4.30 5.10 5.87 6.80 7.00
99 >14 3.28 3.89 4.40 5.15 6.02 7.11 7.50
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SUA levels, followed by triglycerides (p = 0.005) and 2 h
glucose (p = 0.03) while HOMA-IR and BMI z-score did
not predict SUA (Table 4).
In children with levels of SUA in the highest quartile,
ORs for high triglycerides and atherogenic ratio were
4.145, (95% CI 1.506–11.407; p = 0.009) and 2.74 (95%CI
1.001–7.343; p = 0.05), respectively. In adolescents,
ORs were for insulin resistance 2.399 (95%CI 1.4–4.113;
p < 0.001); IFG 2.184 (95%CI 0.877–5.441; p = 0.07); IGT
2.390, (95% CI 1.405–4.063; p = 0.001); high triglycerides
1.8 (95%CI 0.950–3.420, p = 0.05) and atherogenic ratio
2.354, (95%CI 1.490–3.718; p < 0.0001).
Discussion
Our study reports first age-and sex-specific percentiles
of serum uric acid in a very large population of over-
weight/obese young Caucasians of Italian ancestry. It
confirms associations of serum uric acid with waist
circumference, triglycerides and glucose tolerance (2 h
glucose) in this population. Mean values of uric acid
were significantly higher in children in the highest quar-
tile of uric acid and both in children and adolescents
with impaired glucose tolerance. Conversely, to belong
to the highest quartile of uric acid was associated with an
increased risk of presenting high triglycerides and athero-
genic profile both in children and adolescents, while
limited to adolescents there was an increased risk of pre-
senting impaired fasting glucose and insulin resistance.
Gender-related trends of SUA concentrations over-
time found in previous studies [5, 22, 23] were con-
firmed in our sample. In a nationally representative
population of 6768 youths aged 12 to 17 years from the
National Health And Nutrition Examination Survey,
NHANES [5], concentrations of SUA raised in the peri-
pubertal period, peaked at the puberty (i.e. 10–12 years
of age in females and 12–14 in males) and reached adult
levels soon afterward. Gender-related differences in the
peaking time almost certainly reflects the different
tempo of the puberty onset [18] with delayed sexual and
skeletal maturation in males [5]. After the puberty and
throughout the adolescence SUA levels are lower in fe-
males likely because of the uricosuric effect of estrogens
on the kidney tubular reabsorption of UA [22] and
higher in males as possible effect of androgens [23]. In
the later adolescence, i.e. ages 15 to 17 years for males
and 13 to 17 years for females, BMI, skinfold thickness
and blood pressure were determinants of SUA concen-
tration stronger than sexual and somatic maturation [5].
Indeed, in our series of obese patients, mean values were
higher than those found in normal-weight individuals as
reported by the NHANES [22].
The study of Tang et al. [7] investigated SUA concen-
tration in obese children and adolescents of Japanese na-
tionality. The authors observed such an association
between SUA and MetS also in children that they con-
cluded hyperuricemia should be yet considered in early
childhood as CVD risk factor [7]. Very recently Bassols et
al. [14] found increased serum uric acid is associated with
cIMT in asymptomatic prepubertal children highlighting
the role of uric acid levels in the shaping of the cardiometa-
bolic risk very early in childhood.
Our findings are in keeping with these reports. SUA
was correlated with metabolic abnormalities both in
children and in adolescents. Patients in the highest quar-
tile of SUA levels were heavier and presented with worst
lipid and insulin metabolism. The best correlation was
seen between levels of SUA and waist circumference.
Ford et al. [10] explored the association between SUA
and components of the MetS in a nationally representa-
tive sample of 1370 adolescents aged 12–17 years from
the NHANES 1999–2002. Patients with the full MetS
had the highest SUA concentrations. The strongest asso-
ciation of SUA was seen with the waist circumference.
In the general population of NHANES, a concentration
of SUA >5.7 mg/dL was associated with an adjusted OR
for MetS of 14.79 (95%CI 7.78–28.11) [10]. In our popu-
lation of exclusive obese patients, this cut-off value cor-
responded to the 90th percentile of SUA in obese males
aged 8 years-old; to the 75th in those aged 10 years-old;
and to the 50th and 10th in males aged 12 and older than
14 years of age, respectively. In girls, it corresponds to
the 90th percentile in girls 6 years-old and to the 50th–
75th in those by the age of 10 years onward. Hence, most
of our obese patients had values of uric acids higher
than 5.7 suggesting the co-occurrence of metabolic ab-
normalities. One of the limitations of the present study
Table 4 Age and metabolic parameters predicting levels of serum uric acid
Model 1 p Model 2 p Model 3 p Model 4 p
Age 0.092 [0.053–0.130] <0.0001 0.096 [0.057–0.134] <0.0001 0.096 [0.058–0.134] <0.0001
BMI z-score
HOMA-IR
2 h glucose 0.005 [0.001–0.010] 0.03
Triglycerides 0.003 [0.001–0.006] 0.001 0.003 [0.001–0.005] 0.005
Waist circumference 0.049 [0.041–0.058] <0.0001 0.035 [0.025–0.046] <0.0001 0.031 [0.020–0.041] <0.0001 0.030 [0.020–0.041] <0.0001
Values are regression coefficients and 95% confidence intervals (in brackets) obtained from multivariable random-effect linear regression
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was the lack of Information on blood pressure. There-
fore, we could not estimate prevalence of the full MetS
and test the diagnostic accuracy of the 5.7 mg/dL cut-off
as well as the association between SUA and blood
pressure. It was a shame since uric acid contributes sig-
nificantly to the pathogenesis of high blood pressure by
activating the renin–angiotensin–aldosterone system dir-
ectly at the vascular level and indirectly by inducing
tubule-interstitial disease and consequent impaired baro-
reflex function [24]. High levels of uric acid in childhood
were associated with high blood pressure at the same
age [11]. The Bogalusa heat study demonstrated that
high SUA in childhood predicts high blood pressure in
adulthood [25] and, viceversa, features of MetS in child-
hood predict high SUA in adulthood [26].
Despite SUA is a CVD risk factor independent of IR
[27], there is a clear relationship between SUA and
hyperinsulinemia/IR levels. Hyperisulinemia/IR cause
both increased production and reduced renal clearance
of urate [28] while the amelioration of IR by low-energy
diet or insulin sensitizing agents was found to decrease
SUA levels [8]. Insulin favors renal urate reabsorption by
stimulating the urate-anion exchanger URAT1 and/or
the Na+-dependent anion cotransporter in brush border
membranes of the renal proximal tubule [29]. In keeping
with this pathogenic evidence, SUA levels paralleled in-
sulin concentrations in our sample.
The strong association found by us and others [10, 13]
with waist circumference confirms the strong link be-
tween uric acid, visceral adiposity and insulin resistance.
In such interplay, increased consumption of dietary fruc-
tose may contribute [30] since fructose ingestion induces
hepatic de novo lipogenesis, leading to increased visceral
fat accumulation and, in turn, to worsened IR. One path-
way to the production of serum uric acid, indeed, is via
dietary fructose that activates the fructokinase metabolic
system and upregulates de novo purine nucleotide synthe-
sis in hepatocytes [31]. In that, SUA would act as marker
of impaired adipogenesis [32] as further confirmed by as-
sociations observed between SUA and triglycerides levels,
reduced HDL-cholesterol and, even better with an en-
hanced ratio of triglycerides to HDL-cholesterol after
adjusting for covariates as seen in our population.
In addition to the lack of information about blood pres-
sure, other important limitations must be acknowledged
in our study, such as the absence of normal weight con-
trols and information on pubertal stage.
In spite of these limitations, strengths of the present
investigation were the large sample-size and the wide
age-range that included preschoolers. Findings of rela-
tively increased levels of uric acid already at this age
supports the hypothesis of an early origin of cardiovas-
cular disease associated with obesity putted forward by
our research group [33].
Conclusion
In conclusion, our study confirms in a large population of
Italian overweight/obese children and adolescents the asso-
ciation of high serum uric acid and metabolic abnormalities
belonging to the MetS. The potential role of SUA as marker
of increased CVD relies on these associations and seems in-
dependent of the degree of insulin resistance.
There is need of further research in large cohorts of chil-
dren and adolescents better phenotyped in relation to their
CVD to prove the cost-effectiveness of measuring routinely
and monitoring overtime SUA in clinical settings.
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